Friday, October 31, 2014

Friday's Finalist: JNJ

The New Jersey health-care products company Johnson & Johnson (JNJ) was the sole survivor from the early rounds of analysis. (See "Friday's Prospects".)

It confirmed Thursday's bull signal today by continuing to trade beyond the 20-day price channel. However, JNJ's chart isn't yet sufficiently bullish to support a trade.

The price peaked on Sept. 24 at $108.77. Today's high so far is $108.18, slightly short of a break beyond resistance.

Until that resistance level is pierced, and decisively so, JNJ can be interpreted as engaging in a counter-trend upward correction within a downtrend.

So I won't take the trade, and plan no further analysis from Thursday's market session.

-- Tim Bovee, Portland, Oregon, Oct. 31, 2014


My shorter-term trading rules can be read here. My longer-term trading rules can be read here. And the classic Turtle Trading rules on which my rules are based can be read here. My very short term volatility trading rules can be read here

Tim Bovee, Private Trader tracks the analysis and trades of a private trader for his own accounts. Nothing in this blog constitutes a recommendation to buy or sell stocks, options or any other financial instrument. The only purpose of this blog is to provide education and entertainment.
No trader is ever 100 percent successful in his or her trades. Trading in the stock and option markets is risky and uncertain. Each trader must make trading decisions for his or her own account, and take responsibility for the consequences.

Creative Commons License

All content on Tim Bovee, Private Trader by Timothy K. Bovee is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Based on a work at

No comments:

Post a Comment